Site For Fleck Ct-155-R-001 Digital Therapeutic (App) Study
Posted Date: Feb 17, 2023
- Investigator: David Fleck
- Specialties:
- Type of Study: Device
The purpose of the proposed study is to evaluate the efficacy and safety of CT-155 as an adjunct treatment to SOC relative to a comparator Digital Control in participants aged 18 years or older diagnosed with experiential negative symptoms of schizophrenia. If demonstrated to be effective, CT-155 may be considered a novel digital therapeutic option as an adjunct treatment for patients diagnosed with experiential negative symptoms of schizophrenia.
Criteria:
(1) Is Willing And Able To Provide Written Informed Consent To Participate In The Study, Attend Study Visits, And Comply With Study-Related Requirements And Assessments. (2) Adult Or Late Adolescent, 18 Years Of Age Or Older At The Time Of Informed Consen
Keywords:
Schizophrenia, Adults, App Study
For More Information:
Sydney Sweeney
513-558-3314
sweenes4@ucmail.uc.edu